EUVIMEDEUVIMED entdecken
Multizentrische Studie

Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience

Phoebe C Power, Kevin X Liu iD, Susan N Chi, Karen D Wright iD, Karen J Marcus, Daphne A Haas-Kogan, Myrsini Ioakeim-Ioannidou, Roshan Sethi, Hesham Elhalawani, David Ebb, Torunn I Yock iD, Shannon M MacDonald und 1 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31628 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Phoebe C Power und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Germinoma, Brain Neoplasms, Craniospinal Irradiation, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Germinoma is the most common intracranial germ cell tumor (IGCT) in children and young adults. Treatment with 24 Gy craniospinal irradiation (CSI) with boost to 40 Gy alone results in excellent survival, irrespective of disease stage. For localized germinoma, recent studies have demonstrated the efficacy of pre‐irradiation induction chemotherapy in decreasing the field and dose of radiation therapy (RT) needed for cure. For metastatic germinoma, however, the optimal RT approach when combined with chemotherapy is unclear. Herein, we present our experience treating patients with metastatic germinoma.

Methods

We performed a retrospective, IRB‐approved study of patients with metastatic intracranial germinoma diagnosed between 1998 and 2023 at BCH, DFCI, BWH, and MGH. Clinical features, treatment details, and outcomes were collected and analyzed using the Kaplan–Meier method and Fisher's exact test.

Results

Twenty‐seven patients with metastatic germinoma were identified. Median age at diagnosis was 15.5 years (range: 6.2–25.9). Six patients received CSI only. Twenty‐one patients received induction chemotherapy followed by CSI, with a median CSI dose of 21 Gy (range: 18–36 Gy) and a median involved field (IF) boost to 36 Gy (range: 30–51.6 Gy). Median duration of follow‐up was 11.3 years (range: 0.24–24.3). There were no recurrences or deaths within the cohort. Analysis of long‐term outcome data revealed a high frequency of endocrinopathies and radiographic CNS vasculopathy.

Conclusions

Our data show that pre‐irradiation induction chemotherapy followed by CSI is associated with excellent overall survival in patients with metastatic germinoma. Importantly, our experience suggests that in combination with induction chemotherapy, 21 Gy CSI may be sufficient as a curative dose in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GerminomaBrain NeoplasmsCraniospinal IrradiationAntineoplastic Combined Chemotherapy ProtocolsHumansAdolescentMaleChildFemaleRetrospective StudiesYoung AdultAdultSurvival RateFollow-Up StudiesCombined Modality TherapyPrognosisInduction ChemotherapyChemoradiotherapy

Stichwörter der Autor:innen

chemotherapygerm cell tumorgerminomametastaticradiation therapy

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Kevin X Liu, Karen D Wright, Torunn I Yock, Kee Kiat Yeo

Förderung

  • NCI NIH HHS

Zitieren

APA

Power, P. C., Liu, K. X., Chi, S. N., Wright, K. D., Marcus, K. J., Haas-Kogan, D. A., Ioakeim-Ioannidou, M., Sethi, R., Elhalawani, H., Ebb, D., Yock, T. I., MacDonald, S. M., & Yeo, K. K. (2025). Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31628

Vancouver

Power PC, Liu KX, Chi SN, Wright KD, Marcus KJ, Haas-Kogan DA, et al. Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31628

BibTeX
@article{Power2025,
  author = {Power, Phoebe C and Liu, Kevin X and Chi, Susan N and Wright, Karen D and Marcus, Karen J and Haas-Kogan, Daphne A and Ioakeim-Ioannidou, Myrsini and Sethi, Roshan and Elhalawani, Hesham and Ebb, David and Yock, Torunn I and MacDonald, Shannon M and Yeo, Kee Kiat},
  title = {Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31628}
}
Kostenlos starten →